LENSai™ Flags Anti-Drug Antibody Risk Early, Says Study
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelligence, today announced results of a newly expanded study demonstrating that its LENSai™ Immunogenicity Screening can reliably predict Anti-Drug-Antibody (ADA) risk…
BostonGene Wins 2025 Frost & Sullivan Award for AI Oncology Innovation
BostonGene Wins 2025 Frost & Sullivan Award for AI Oncology Innovation
BostonGene’s comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development risk and advance precision oncology across all stages the R&D continuum Frost & Sullivan has named BostonGene the...
Waterdrop Joins HBS Case Collection for AI in Health & Insurance
Waterdrop Joins HBS Case Collection for AI in Health & Insurance
The business innovation case of Waterdrop Inc. (NYSE:WDH), Waterdrop: AI-Powered Insurance and Healthcare, was recently included in Harvard Business School (HBS)’s Case Collection, receiving recognition from...
Treatment.com AI Gains Momentum Post Rocket Doctor Acquisition
Treatment.com AI Gains Momentum Post Rocket Doctor Acquisition
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) and its wholly owned digital health platform and marketplace, Rocket...
C-mo Medical Earns ISO 13485 for AI-Powered Cough Monitor
C-mo Medical Earns ISO 13485 for AI-Powered Cough Monitor
C-mo Medical Solutions, a leading provider of next-generation cough-monitoring technology, is pleased to announce that it has received ISO 13485:2016...